Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)
Conditions
Urothelial Carcinoma · Advanced Urothelial Carcinoma · Urothelial Carcinoma Recurrent
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China
Sun yat-sen university cancer center, Guangzhou, Guangdong, China
The fifth Affiliated Hospital of Guangzhou Medcial University, Guangzhou, Guangdong, China
Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China
Jiangxi Cancer Center, Nanchang, Jiangxi, China
The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
Study leads
Yanxia Shi, Doctor
Principal Investigator
Sun Yat-Sen University Cancer Center